Nirogacestat in Ovarian Granulosa Cell Tumors

Clinical trial NCT05348356 · COMPLETED

Trial details

NCT number: NCT05348356
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Granulosa-Stromal Tumor Ovarian Granulosa Cell Tumor Ovarian Cancer

Start date: 2022-08-30
Primary completion: 2025-07-08
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.